Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
Open Access
- 11 July 2025
- journal article
- Published by Wiley in Annals of Neurology
- Vol. 98 (3) , 482-491
Abstract
Objective: To determine the impact of dopamine deficiency and isolated rapid eye movement (REM) sleep behavior disorder (iRBD) on cognitive performance in early neuronal α‐synuclein disease (NSD) with hyposmia but without motor disability.Methods: Using Parkinson's Progression Markers Initiative baseline data, cognitive performance was assessed with a cognitive summary score (CSS) derived from robust healthy control (HC) norms. Performance was examined for participants with hyposmia in early NSD‐Integrated Staging System (NSD‐ISS), either stage 2A (cerebrospinal fluid α‐synuclein seed amplification assay [SAA]+, dopamine transporter scan [DaTscan]−) or 2B (SAA+, DaTscan+).Results: Participants were stage 2A (n = 101), stage 2B (N = 227), and HCs (n = 158). Although stage 2 had intact Montreal Cognitive Assessment scores (mean [SD] = 27.0 [2.3]), stage 2A had a numerically worse CSS (z‐score mean difference = 0.05, p = NS; effect size = 0.09) and stage 2B a statistically worse CSS (z‐score mean difference = 0.23, p < 0.05; effect size = 0.40) compared with HCs. In stage 2A, hyposmia alone was associated with normal cognition, but those with comorbid iRBD had significantly worse cognition (z‐score mean difference = 0.33, p < 0.05, effect size =0.50). In stage 2B, hyposmia alone had abnormal cognition (z‐score mean difference = 0.18, p = 0.0078, effect size = 0.29), and superimposed iRBD had a statistically significant additive effect.Interpretation: Using a novel CSS, we demonstrated that hyposmia is associated with cognitive deficits in prodromal NSD without motor disability, particularly when comorbid dopamine system impairment or comorbid iRBD is present. Therefore, it is critical to include and assess cognition at all stages when studying synuclein disease, even in the absence of motor disability. ANN NEUROL 2025;98:482–491Keywords
Funding Information
- Michael J. Fox Foundation
This publication has 36 references indexed in Scilit:
- Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to SynucleinopathyAnnals of Neurology, 2024
- Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter studyAlzheimer's & Dementia, 2023
- The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohortAnnals of Clinical and Translational Neurology, 2018
- Selection of Normative Group Affects Rates of Mild Cognitive Impairment in Parkinson's DiseaseMovement Disorders, 2018
- Cognition and the course of prodromal Parkinson's diseaseMovement Disorders, 2017
- Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter–Deficit Prodromal CohortJAMA Neurology, 2017
- Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findingsMovement Disorders, 2015
- Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseMovement Disorders, 2015
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 yearsMovement Disorders, 2008
- Prevalence and Characteristics of Dementia in Parkinson DiseaseArchives of Neurology, 2003